サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751223

製薬・ヘルスケア向け活性炭の市場規模、シェア、動向分析レポート：形態別、用途別、地域別、セグメント予測、2025年～2030年

Activated Carbon For Pharma & Healthcare Market Size, Share & Trends Analysis Report By Form (Powdered, Granular), By Application (API Production, Finished Drug Production), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 132 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
製薬・ヘルスケア向け活性炭の市場規模、シェア、動向分析レポート：形態別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月05日
発行: Grand View Research
ページ情報: 英文 132 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

製薬・ヘルスケア向け活性炭市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、製薬・ヘルスケア向け活性炭の世界市場規模は2030年までに6億5,210万米ドルに達すると予測され、2025年から2030年までのCAGRは6.3%で成長する見込みです。

製薬およびヘルスケア分野における活性炭の需要は成長を続けており、その主な理由は汚染物質を浄化・吸着する優れた能力です。病院では、清潔な空気と水を維持するために重要な役割を果たし、医薬品製造では、薬から不純物や不要な着色料を除去するために使用されます。人体への使用が許可されている医療グレードの活性炭は、救急医療において毒物中毒を治療するための重要なツールでもあります。活性炭は消化管内で毒素と結合し、体内への毒素の吸収を阻止します。

毎年、入院患者の約5％から10％にあたる約170万人の患者がHAIを発症し、その結果10万人近くが死亡しています。この数字は、他の多くの主要疾患の影響を上回る深刻な公衆衛生上の懸念を浮き彫りにしています。この問題に対処するため、ヘルスケア施設は高度な浄化技術に目を向けており、中でも活性炭は有害な粒子や病原体を効率的にろ過できるため、最有力候補となっています。

さらに、活性炭はその高い気孔率と優れた吸着能力により、製薬業界で多用されています。これらの特性により、医薬品製造時の汚染物質、顔料、残留物を効果的に除去し、最終製品の品質と安全性を向上させることができます。

製薬・ヘルスケア向け活性炭市場のハイライト

  • 形態別では、粉末状が2024年に56.3%の最大売上シェアで市場を独占。
  • 製薬・ヘルスケア向け粒状活性炭市場は、市場推計・予測期間中に最も速いCAGRで成長すると推定されます。
  • 吸収性に優れ、取り扱いや保管が容易で、繰り返しのろ過サイクルに耐えられることが成長の原動力となっています。
  • 用途別では、原薬製造が製薬・ヘルスケア産業の活性炭市場をリードし、2024年に最大の収益シェアを占める。
  • 完成品医薬品製造分野は、予測期間中にCAGR 6.2%という大幅な成長が見込まれています。
  • アジア太平洋地域が2024年に48.6%の最大収益シェアを占め、世界市場を独占しました。
  • アジア諸国における医薬品製造の増加が、製造時におけるより効率的な精製方法への需要を煽りました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 製薬・ヘルスケア向け活性炭の市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連市場見通し
  • 業界バリューチェーン分析
  • 規制の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題
    • 業界の機会
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • マクロ環境分析

第4章 製薬・ヘルスケア向け活性炭の市場：形態推定・動向分析

  • セグメントダッシュボード
  • 製薬・ヘルスケア向け活性炭の市場：形態変動分析と市場シェア、2024年と2030年
  • 粉末
  • 粒状
  • その他の形態

第5章 製薬・ヘルスケア向け活性炭の市場：用途推定・動向分析

  • セグメントダッシュボード
  • 製薬・ヘルスケア向け活性炭の市場：用途変動分析と市場シェア、2024年と2030年
  • API製造
    • 製薬・ヘルスケア市場収益推計と予測（API製造分野、2018年～2030年）
  • 完成医薬品生産
    • 製薬・ヘルスケア市場収益推計と予測（完成医薬品生産、2018年～2030年）
  • その他
    • 製薬・ヘルスケア向け活性炭市場収益推計と予測（その他の用途）、2018年～2030年

第6章 製薬・ヘルスケア向け活性炭の市場：地域推定・動向分析

  • 地域変動分析と市場シェア、2024年と2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア

第7章 製薬・ヘルスケア向け活性炭の市場-競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ
  • ポジション分析、2024年
  • 戦略マッピング
    • 拡大
    • 合併と買収
    • パートナーシップとコラボレーション
    • 新しいフォームのリリース
    • 研究開発
  • 企業プロファイル
    • Jacobi Group
    • Chemviron（a Kuraray Company）
    • Haycarb PLC
    • Boyce Carbon
    • Southern Carbon Pvt. Ltd.
    • Suneeta Carbons
    • Calgon Carbon Corporation
    • Karbonous Inc.
    • Norit
    • Donau Carbon GmbH
図表

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Activated carbon for pharma & healthcare market 2018 - 2030 (Kilotons) (USD Million)
  • Table 3. Global activated carbon for pharma & healthcare market estimates and forecasts by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 4. Global activated carbon for pharma & healthcare market estimates and forecasts by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 5. Global activated carbon for pharma & healthcare market estimates and forecasts by region, 2018 - 2030 (Kilotons) (USD Million)
  • Table 6. North America activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 7. North America activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 8. North America activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 9. U.S. activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 10. U.S. activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 11. Canada activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 12. Canada activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 13. Mexico activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 14. Mexico activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 15. Europe activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 16. Europe activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 17. Europe activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 18. Germany activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 19. Germany activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 20. UK activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 21. UK activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 22. France activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 23. France activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 24. Italy activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 25. Italy activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 26. Spain activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 27. Spain activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 28. Asia Pacific activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 29. Asia Pacific activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 30. Asia Pacific activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 31. China activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 32. China activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 33. India activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 34. India activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 35. Japan activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 36. Japan activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 37. South Korea activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 38. South Korea activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 39. Australia activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 40. Australia activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 41. Latin America activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 42. Latin America activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 43. Latin America activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 44. Brazil activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 45. Brazil activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 46. Argentina activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 47. Argentina activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 48. Middle East & Africa activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 49. Middle East & Africa activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 50. Middle East & Africa activated carbon for pharma & healthcare market by country, 2018 - 2030 (Kilotons) (USD Million)
  • Table 51. South Africa activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 52. South Africa activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)
  • Table 53. Saudi Arabia activated carbon for pharma & healthcare market by form, 2018 - 2030 (Kilotons) (USD Million)
  • Table 54. Saudi Arabia activated carbon for pharma & healthcare market by application, 2018 - 2030 (Kilotons) (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 QFD Modeling for Market Share Assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 Activated Carbon For Pharma & Healthcare Market Snapshot
  • Fig. 11 Form Segment Snapshot (1/2)
  • Fig. 12 Application Segment Snapshot (1/2)
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 Activated Carbon For Pharma & Healthcare Market Value, 2024 (Kilotons) (USD Million)
  • Fig. 16 Activated Carbon For Pharma & Healthcare Market - Value Chain Analysis
  • Fig. 17 Activated Carbon For Pharma & Healthcare Market - Market Dynamics
  • Fig. 18 Activated Carbon For Pharma & Healthcare Market - PORTER's Analysis
  • Fig. 19 Activated Carbon For Pharma & Healthcare Market - PESTEL Analysis
  • Fig. 20 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Form: Key Takeaways
  • Fig. 21 Activated Carbon For Pharma & Healthcare Market Share, By Form, 2024 & 2030
  • Fig. 22 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Powdered Form, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 23 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Granular Form, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 24 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Application: Key Takeaways
  • Fig. 25 Activated Carbon For Pharma & Healthcare Market Share, By Application, 2024 & 2030
  • Fig. 26 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in API Production, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 27 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Finished Drug Production, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 28 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Others, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 29 Activated Carbon For Pharma & Healthcare Market Revenue, By Region, 2024 & 2030 (Kilotons) (USD Million)
  • Fig. 30 North America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 31 U.S. Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 32 Canada Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 33 Mexico Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 34 Europe Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 35 Germany Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 36 UK Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 37 France Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 38 Italy Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 39 Spain Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 40 Asia Pacific Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 41 China Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 42 India Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 43 Japan Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 44 South Korea Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 45 Australia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 46 Latin America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 47 Brazil Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 48 Argentina Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 49 Middle East & Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 50 South Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 51 Saudi Arabia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Fig. 52 Key Company Categorization
  • Fig. 53 Company Market Positioning
  • Fig. 54 Strategy Mapping
目次
Product Code: GVR-4-68040-564-7

Activated Carbon For Pharma & Healthcare Market Growth & Trends:

The global activated carbon for pharma & healthcare market size is anticipated to reach USD 652.1 million by 2030 and is expected to grow at a CAGR of 6.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for activated carbon in the pharmaceutical and healthcare sectors continues to grow, largely due to its exceptional ability to purify and adsorb contaminants. In hospitals, it plays a vital role in maintaining clean air and water, while in pharmaceutical manufacturing, it's used to remove impurities and unwanted colorants from medications. Medical-grade activated carbon, approved for human use, is also a critical tool in emergency medicine for treating poisonings. It works by binding to toxins in the gastrointestinal tract, stopping them from being absorbed into the body, a life-saving measure in cases of overdose or accidental ingestion.

This rising demand is also tied to the significant challenge posed by hospital-acquired infections (HAIs) in the U.S. Each year, approximately 1.7 million patients, roughly 5% to 10% of those hospitalized, develop an HAI, with close to 100,000 resulting deaths. These numbers highlight a serious public health concern that exceeds the impact of many other major diseases. To combat this, healthcare facilities are turning to advanced purification technologies, with activated carbon being a top choice due to its efficiency in filtering harmful particles and pathogens.

In addition, activated carbon is heavily utilized in the pharmaceutical industry for its high porosity and excellent adsorption capabilities, which are enhanced through thermal processing. These properties allow it to effectively remove contaminants, pigments, and residues during drug production, improving the final product's quality and safety.

Activated Carbon For Pharma & Healthcare Market Highlights

  • Based on form, the powdered form dominated the market with the largest revenue share of 56.3% in 2024.
  • The granular activated carbon market for the pharmaceutical and healthcare industry is estimated to grow at the fastest CAGR over the forecast period.
  • Its superior absorption, easy handling, storage, and ability to withstand repeated filtration cycles drive the growth.
  • Based on application, API production led the activated carbon market for the pharma & healthcare industry, accounting for the largest revenue share in 2024.
  • The finished drug production segment is expected to grow at a significant CAGR of 6.2% over the forecast period.
  • Asia Pacific dominated the global market with the largest revenue share of 48.6% in 2024.
  • The rise in pharmaceutical production across Asian countries fueled the demand for more efficient purification methods during production.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Activated Carbon For Pharma & Healthcare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
    • 3.4.4. Industry Opportunities
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Macro-environmental Analysis

Chapter 4. Activated Carbon For Pharma & Healthcare Market: Form Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Activated Carbon For Pharma & Healthcare Market: Form Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Powdered
    • 4.3.1. Powdered Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)
  • 4.4. Granular
    • 4.4.1. Granular Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)
  • 4.5. Other Form
    • 4.5.1. Other Form Market Revenue Estimates and Forecasts, 2018 - 2030 (Kilotons, USD Million)

Chapter 5. Activated Carbon For Pharma & Healthcare Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Activated Carbon For Pharma & Healthcare Market: Application Movement Analysis & Market Share, 2024 & 2030
  • 5.3. API Production
    • 5.3.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in API Production, 2018 - 2030 (Kilotons, USD Million)
  • 5.4. Finished Drug Production
    • 5.4.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Finished Drug Production, 2018 - 2030 (Kilotons, USD Million)
  • 5.5. Others
    • 5.5.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Other Applications, 2018 - 2030 (Kilotons, USD Million)

Chapter 6. Activated Carbon For Pharma & Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Movement Analysis & Market Share, 2024 & 2030
  • 6.2. North America
    • 6.2.1. North America activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key country dynamics
      • 6.2.2.2. U.S. activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key country dynamics
      • 6.2.3.2. Canada activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key country dynamics
      • 6.2.4.2. Mexico activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.3. Europe
    • 6.3.1. Europe activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Germany activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. UK activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. France activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key country dynamics
      • 6.3.5.2. Italy activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key country dynamics
      • 6.3.6.2. Spain activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.2. China
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. China activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.3. India
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. India activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Japan activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. South Korea activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Australia activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Brazil activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Argentina activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. South Africa activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Saudi Arabia activated carbon for pharma & healthcare market estimates & forecast, 2018 - 2030 (Kilotons, USD Million)

Chapter 7. Activated Carbon For Pharma & Healthcare Market - Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map
  • 7.4. Position Analysis, 2024
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Form Launches
    • 7.5.5. Research And Development
  • 7.6. Company Profiles
    • 7.6.1. Jacobi Group
      • 7.6.1.1. Participant's overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Form benchmarking
      • 7.6.1.4. Recent developments
    • 7.6.2. Chemviron (a Kuraray Company)
      • 7.6.2.1. Participant's overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Form benchmarking
      • 7.6.2.4. Recent developments
    • 7.6.3. Haycarb PLC
      • 7.6.3.1. Participant's overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Form benchmarking
      • 7.6.3.4. Recent developments
    • 7.6.4. Boyce Carbon
      • 7.6.4.1. Participant's overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Form benchmarking
      • 7.6.4.4. Recent developments
    • 7.6.5. Southern Carbon Pvt. Ltd.
      • 7.6.5.1. Participant's overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Form benchmarking
      • 7.6.5.4. Recent developments
    • 7.6.6. Suneeta Carbons
      • 7.6.6.1. Participant's overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Form benchmarking
      • 7.6.6.4. Recent developments
    • 7.6.7. Calgon Carbon Corporation
      • 7.6.7.1. Participant's overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Form benchmarking
      • 7.6.7.4. Recent developments
    • 7.6.8. Karbonous Inc.
      • 7.6.8.1. Participant's overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Form benchmarking
      • 7.6.8.4. Recent developments
    • 7.6.9. Norit
      • 7.6.9.1. Participant's overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Form benchmarking
      • 7.6.9.4. Recent developments
    • 7.6.10. Donau Carbon GmbH
      • 7.6.10.1. Participant's overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Form benchmarking
      • 7.6.10.4. Recent developments